Pharmafile Logo
Pharmafocus logo
Advanced Search

merck sharp and dohme

Showing 6 posts of 6 posts found.

keytruda

FDA approves Merck’s Keytruda for advanced NSC lung cancer

October 5, 2015
Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo

The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …

News

Price concession helps change NICE’s mind on Simponi

May 13, 2011
Sales and Marketing NICE, Simponi, TNF, merck sharp and dohme

NICE has provisionally recommended Merck Sharp & Dohme’s Simponi for rheumatoid arthritis alongside other drugs in the TNF inhibitor class. …

News
merck_sharp_dohme_deepak_khanna

MSD’s Deepak Khanna to chair American Pharmaceutical Group

March 17, 2011
Research and Development, Sales and Marketing American Pharmaceutical Group, Deepak Khanna, MSD, merck sharp and dohme

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …

Appointment

Working Life: Merck Sharp & Dohme medical director Paul Robinson

February 4, 2011
Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment

Paul Robinson, medical director at Merck Sharp & Dohme, looks at how his field is changing, the most enjoyable things …

News

Merck wins double approval in Europe

September 3, 2010
Sales and Marketing Brinavess, Merck & Co, Syncrest, merck sharp and dohme

European regulators have given the green light for two of Merck & Co’s new drugs, licensing its anti-psychotic treatment Sycrest …

News

MSD launches asthma training resources

August 6, 2010
Medical Communications, Sales and Marketing MSD, asthma, medical education, merck sharp and dohme, nurses

A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026